講演・口頭発表等 - 田中　一

21. 范 博, 横山 みなと, Chen Wei, 小林 正貴, 福田 翔平, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藍 真澄, 伏見 清秀, 藤井 靖久. ロボット支援膀胱全摘除における尿路変向の割合および尿路変向ごとの手術成績　DPCデータベースによる全国調査(Distribution of urinary diversion and surgical outcomes of robot-assisted radical cystectomy: a Japanese nationwide database study). 日本泌尿器科学会総会 2023.04.01

22. Chen Wei, Yokoyama Minato, Waseda Yuma, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: a Japanese nationwide study(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

23. Fukuda Shohei, Saito Kazutaka, Nakayama Akinori, Inoue Masaharu, Tanaka Hajime, Ito Masaya, Numao Noboru, Yuasa Takeshi, Koga Fumitaka, Yonese Junji, Kageyama Yukio, Fujii Yasuhisa. Significance of C-reactive protein flare-response in patient with metastatic renal cell carcinoma treated with first-line immuno-oncology combination therapy. the 110th Annual Meeting of the Japanese Urological Association 2023.04.01

24. Nakamura Yuki, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa. Significance of adrenal metastasectomy based on classification of oligometastasis(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

25. Fujiwara Motohiro, Yoshida Soichiro, Takahara Taro, Soma Takahiko, Yoshitomi Kasumi, Nakamura Yuki, Fan Bo, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Prostate and Metastasis Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Hormone-naieve Prostate Cancer(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

26. 浅井 真太郎, 小林 正貴, 福田 翔平, 木村 浩一郎, 范 博, 藤原 基裕, 中村 祐基, 石川 雄大, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 横山 みなと, 藤井 靖久. PI-RADS version 2.1における著明な拡散制限を有するatypical noduleのcategory 3へのアップグレードの妥当性(Significance of atypical nodules upgraded to category 3 by abnormal DWI finding in PI-RADS version 2.1 for prostate cancer diagnosis). 日本泌尿器科学会総会 2023.04.01

27. Yoshida Souichirou, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

28. Waseda Yuma, Yokoyama Minato, Yoshitomi Kasumi, Souma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Tanaka Hajime, Yoshida Souichirou, Fujii Yasuhisa. Longitudinal evaluation of lower urinary tract symptoms after artificial urinary sphincter implantation using the core lower urinary tract symptom score(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

29. 田中 一, 布川 裕規, 山本 浩平, 谷本 幸介, 竹本 暁, 蓮見 壽史, 平川 晃弘, 石川 雄大, 福田 翔平, 早稲田 悠馬, 吉田 宗一郎, 横山 みなと, 藤井 靖久. 淡明細胞型腎細胞癌における腎実質浸潤/進展の意義　予後への影響と遺伝学的背景. 日本泌尿器科学会総会 2023.04.01

30. 横山 みなと, Chen Wei, 小林 正貴, 范 博, 福田 翔平, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藍 真澄, 伏見 清秀, 藤井 靖久. 膀胱全摘除のトレンドと術式による手術成績の比較　DPCデータベースに基づく全国調査(Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches: A Japanese nationwide database study). 日本泌尿器科学会総会 2023.04.01

31. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

32. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

33. Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

34. Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

35. Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate. the 37th Annual European Association of Urology(EAU) Congress 2022.07

36. Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. Cribriform cancer is equally visible to non-cribriform cancer on multiparametric MRI: An analysis using texture features. the 37th Annual European Association of Urology(EAU) Congress 2022.07

37. Fukuda S, Tanaka H, Tanabe K, Tamiya T, Kobayashi M, Yajima S, Nakamura Y, Fujiwara M, Ishikawa Y, Yamamoto T, Araki S, Yoshida S, Yokoyama M, Matsuoka Y, Otsuka Y, Koga F, Fujii Y. Local recurrence following partial nephrectomy in patients with renal cell carcinoma: a multicenter study. The 117th annual meeting of the American Urological Association 2022.05.13 New Orleans, USA

38. Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

39. Uchida Y, Yokoyama M, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. ASSESSMENT OF ERECTILE AND EJACULATORY FUNCTIONS AFTER BLADDER-SPARING THERAPY AGAINST MUSCLE-INVASIVE BLADDER CANCER. the 22nd World Meeting of the International Society for Sexual Medicine 2022.05

40. Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa, Yoshimura Ryoichi, Tateishi Ukihide. 筋層浸潤膀胱癌に対する膀胱温存療法の治療効果予測におけるVI-RADSの臨床的意義(Clinical Significance of the Vesical Imaging Reporting and Data System in Predicting the Therapeutic Effect of Bladder-Sparing Treatment in Muscle-Invasive Bladder Cancer). 日本医学放射線学会学術集会抄録集 2022.03.01